Status:
COMPLETED
Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic)
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
University of Montpellier 3 (Pr. Stéphane Raffard, PhD)
University of Reims Champagne-Ardenne (Ali Oker PhD)
Conditions:
Mental Disorder
General Population
Eligibility:
All Genders
18+ years
Brief Summary
France has been put on a lockdown for 8 weeks to prevent the spread of the COVID-19 virus between 17/03/2020 and 11/05/2020. During this lockdown, which is likely to have psychopathological repercussi...
Detailed Description
Indeed, it has been reported that under continued stress, delusions and psychotic experiences can occur in the general population. This phenomenon is found in individuals suffering from depression and...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Individuals from the general population
- French native speacker
- Majority 18 years and more
- Exclusion criteria:
- Patient refusing to participate in research
Exclusion
Key Trial Info
Start Date :
May 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04384419
Start Date
May 29 2020
End Date
June 1 2021
Last Update
January 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UH Montpellier
Montpellier, France, 34295